SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-23-000805
Filing Date
2023-04-28
Accepted
2023-04-28 06:02:17
Documents
8

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS uthr4146911-defa14a.htm DEFA14A 42065
2 GRAPHIC uthr4146911-defa14a1x1x1.jpg GRAPHIC 34764
3 GRAPHIC uthr4146911-defa14a1x1x2.jpg GRAPHIC 5092
4 GRAPHIC uthr4146911-defa14a1x1x3.jpg GRAPHIC 5673
5 GRAPHIC uthr4146911-defa14a1x1x4.jpg GRAPHIC 4878
6 GRAPHIC uthr4146911-defa14a1x1x5.jpg GRAPHIC 1520
7 GRAPHIC uthr4146911-defa14a1x2x1.jpg GRAPHIC 1174
8 GRAPHIC uthr4146911-defa14ax1x1logo.jpg GRAPHIC 7921
  Complete submission text file 0001308179-23-000805.txt   128357
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26301 | Film No.: 23859828
SIC: 2834 Pharmaceutical Preparations